Abstract
Central nervous system (CNS) relapse is an uncommon devastating complication of diffuse large B-cell lymphoma (DLBCL) that usually occurs within 2 years from initial diagnosis. Its pathophysiology is poorly understood and there is no consensus on the definition of high-risk patients for CNS relapse. …
Cite
CITATION STYLE
APA
T, S., & N, G. (2012). CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom? Blood Reviews, 26(3), 97–106. Retrieved from https://linkinghub.elsevier.com/retrieve/pii/S0268960X11000932 papers3://publication/doi/10.1016/j.blre.2011.12.001
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free